Loss of p21(WAF1/Cip1) protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers

Clinical Cancer Research

Volumn 4, Issue 5, 1998, Pages 1251-1261

  Sinicrope, Frank A ^a,b   Roddey, Gardiner ^a   Lemoine, Michael ^a   Ruan, Sanbao ^a   Stephens, L Clifton ^a   Frazier, Marsha L ^a   Shen, Yu ^a   Zhang, Wei ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Box 78 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; PROTEIN P53; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; BASE MISPAIRING; COLORECTAL CANCER; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; CELL CULTURE; COLORECTAL TUMOR; DISEASE COURSE; GENETICS; METABOLISM; MUTATION; PATHOLOGY; TUMOR SUPPRESSOR GENE;

COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DISEASE PROGRESSION; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; NEOPLASM PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031596882     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. 1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
2. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
3. Waga, S., Hannon, G. J., Beach, D., and Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (Lond.), 369: 574-578, 1994.
4. Luo, Y., Hurwitz, J., and Massague, J. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature (Lond.), 375: 159-161, 1995.
5. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
6. Waldman, T., Kinzler, K. W., and Vogelstein, B. p21 is necessary for the p53-mediated GI arrest in human cancer cells. Cancer Res., 55: 5187-5190, 1995.
7. Baker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S., Willson, J. K. V., Hamilton, S., and Vogelstein, B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50: 7717-7722, 1990.
8. Yang, Z. Y., Perkins, N. D., Ohno, T., Nabel, E. G., and Nabel, G. J. The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nat. Med, 1: 1052-1056, 1995.
9. WAF1. Cancer Res., 55: 4536-4539, 1995.
10. 1 checkpoint control. Cell, 82: 675-784, 1995.
11. 1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
12. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., and Van Dyke, T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78: 703-711, 1994.
13. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. Induction of WAF1/Cip1 by a p53-independent pathway. Cancer Res., 54: 3391-3395, 1994.
14. Parker, S. B., Eichele, G., Zhang, P., Rawls, A., Sands, A. T., Bradley, A., Olson, E. N., Harper, J. W., and Elledge, S. J. p53-independent expression of p21WAF1/Cip1 in muscle and other terminally differentiating cells. Science (Washington DC), 267: 1024-1027, 1995.
15. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T. p53-dependent and independent expression of p21 during cell growth differentiation, and DNA damage. Genes Dev., 9. 935-944, 1995.
16. Zhang, W., Grasso, L., McClain, C. D., Gambel, A. M., Cha, Y., Travail, S., Deisseroth, A. B., and Mercer, W. E. p53-independent induction of WAF1/Cip1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res., 55: 668-675, 1995.
17. Marchetti, A., Doglioni, C., Barbareschi, M., Buttitta, F., Pellegrini, S., Bertacca, G., Chella, A., Merlo, G., Alberto, Angeletti, C., Dalla Palma, P., and Bevilacqua, G. p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene, 12: 1319-1324, 1996.
18. Elbendary, A. A., Cirisano, F. D., Evans, A. C., Jr., Davis, P. L., Iglehart, J. D., Marks, J. R., and Berchuck, A. Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells. Clin. Cancer Res., 2: 1571-1575, 1996.
19. WAF1/cip1 expression in normal and neoplastic tissues. Cancer Res., 55: 2910-2919, 1995.
20. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
21. Lynch, H. T., and Smyrk, T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer (Phila.), 78: 1149-1167, 1996.
22. Dietmaier, W., Wallinger, S., and Bocker, T. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res, 57: 4749-4756, 1997.
23. Jeon, H. M., Lynch, P. M., Howard, L., Ajani, J., Levin, B., and Frazier, M. L. Mutation of the hMSH2 gene in two families with hereditary nonpolyposis colorectal cancer. Hum. Mutat., 7: 327-333, 1996.
24. Thibodeau, S. N., French, A. J., Roche, P. C., Cunningham, J. M., Tester, D. J., Lindor, N. M., Moslein, G., Baker, S. M., Liskay, R. M., Burgart, L. J., Honchel, R., and Hailing, K. C. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res, 56: 4835-4840, 1996.
25. Sinicrope, F. A., Ruan, S., Cleary, K. R., Stephens, L. C., Lee, J. J., and Levin, B. Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res., 55: 237-241, 1995.
26. wAF1/cip1 in human brain tumors. Oncogene, 11: 2021-2028, 1995.
27. Sinicrope, F. A., Roddey, G., McDonnell, T. J., Shen, Y., and Stephens, L. C. Increased apoptosis accompanies neoplastic development in the human colorectum. Clin Cancer Res., 2: 1999-2006, 1996.
28. Schulze-Osthoff, K., Wakzcak, H., Dröge, W., and Krammer, P. H. Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol, 127: 15-20, 1994.
29. Ansari, B., Coates, P. J., Greenstein, B. D., and Hall, P. A. In situ end-labeling detects DNA strand breaks in apoptosis and other physiological and pathological states. J. Pathol., 170: 1-8, 1993.
30. Baas, I. O., Mulder, J. R., Offerhaus, G. J. A., Vogelstein, B., and Hamilton, S. J. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol., 172: 5-12, 1994.
31. Matsui, S. I., Arrendondo, M. A., Wrzosek, C., and Rustum, Y. M. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells. Cancer Res, 56: 4715-4723, 1996.
32. 1 phase arrest and p53 function in human tumor cells. Cancer Res., 55: 1842-1846, 1995.
33. Doglioni, C., Pelosio, P., Laurino, L., Macri, E., Meggiolaro, E., Favretti, F., and Barbareschi, M. p21 WAF1/Cip1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation. J. Pathol., 179: 248-253, 1996.
34. Jung, J. M., Li, H., Kobayashi, T., Kyritsis, A. P., Langford, L. A., Bruner, J. M., Levin, V., and Zhang, W. Inhibition of human glioblastoma cell growth by WAF1/Cip1 can be attenuated by mutant p53. Cell Growth Differ., 6: 909-913, 1995.
35. Konishi, M., Kikuchi-Yanoshita, R., Tanaka, K., Muraoka, M., Onda, A., Okumura, Y., Kishi, N., Iwama, T., Mori, T., Koike, M., Ushio, K., Chiba, M., Nomizu, S., Konishi, F., Utsunomiya, J., and Miyaki, M. Molecular nature of colon tumors in hereditary non-polyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology, 111: 307-317, 1996.
36. Losi, L., Fante, R., Di Gregorio, C., Aisoni, M. L., Lanza, G., Maestri, I., Roncucci, L., Pedroni, M., and Ponz de Leon, M. Biologic characterization of hereditary non-polyposis colorectal cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. Am. J. Clin. Pathol., 103: 265-270, 1995.
37. Cottu, P. H., Muzeau, F., Estreicher, A., Flejou, J. F., Iggo, R., Thomas, G., and Hamelin, R. Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines. Oncogene, 13: 2727-2730, 1996.
38. WAF1 and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up. Clin. Cancer Res., 2: 1591-1599, 1996.
39. Zhang, W., Kornblau, S. M., Kobayashi, T., Gambel, A., Claxton, D., and Deisseroth, A. B. High level of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia. Clin. Cancer Res., 1: 1051-1057, 1995.
40. Li, Y. J., Laurent-Puig, P., Salmon, R. J., Thomas, G., and Hamelin, R. Polymorphisms and probable lack of mutation in the WAF1-Cip1 gene colorectal cancer. Oncogene, 10: 599-601, 1995.
41. Koopman, J., Maintz, D., Schild, S., Schramm, J., Lousi, D. N., Wiestler, O. D., and von Deimling, A. Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumors. Br. J. Cancer, 72: 1230-1233, 1995.
42. Gartel, A. L., Serfas, M. S., and Tyner, A. L. p21-negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med., 213: 138-149, 1996.
43. Li, C. Y., Suardet, L., and Little, J. B. Potential role of WAF1/ Cip1/p21 as a mediator of TGF-β cytoinhibitory effect. J. Biol. Chem., 270: 4971-4974, 1995.
44. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
45. Steinman, R. A. Hoffman, B., Iro, A., Guillouf, C., Liebermann, D. A., and El-Houseini, M. E. Induction of p21 (WAF1/Cip1) during differentiation. Oncogene, 9: 3389-3396, 1994.
46. Barboule, N., Mazars, P., Baldin, V., Vidai, S., Jozan, S., Martel, P., and Valette, A. Expression of p21WAF1/Cip1 in heterogeneous and unrelated to proliferation index in human ovarian carcinoma. Int. J. Cancer, 63: 611-615, 1995.
47. Hermking, H., Funk, J. O., Reichert, M., Ellwart, J. W., and Eick, D. Abrogation of p53-induced cell cycle arrest by c-Myc: evidence for an inhibitor of p21 WAF1/Cip1/SDI1. Oncogene, 11: 1409-1415, 1995.
48. 1 arrest. Proc. Natl. Acad. Sci. USA, 91: 10079-10083, 1994.
49. Milross, C. G., Mason, K. A., Hunter, N. R., Chung, W. K., Peters, L. J., and Milas, L. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J. Natl. Cancer Inst., 88: 1308-1314, 1996.
50. Meyn, R. E., Stephens, L. C, and Milas, L. Programmed cell death and radioresistance. Cancer Metastasis Rev., 15: 119-131, 1996.
51. Kobayashi, T., Consoli, U., Andreeff, M., Shiku, H., Dcisseroth, A. B., and Zhang, W. Activation of p21WAF1/Cip1 expression by a temperature-sensitive mutant of human p53 does not lead to apoptosis. Oncogene, 11: 2311-2316, 1995.
52. Waldman, T., Lengauer, C., Kinzler, K. W., and Vogelstein, B. Uncoupling of S-phase and mitosis induced by anti-cancer agents in cells lacking p21. Nature (Lond.), 381: 713-716, 1996.
53. Malkhosyan, S., McCarty, A., Sawai, H., and Perucho, M. Differences in the spectrum of spontaneous mutations in the hprt gene between tumor cells of the microsatellite mutator phenotype. Mutat. Res, 316: 249-259, 1996.
54. McDonald, E. R., Wu, G. S., Waldman, T., and El-Deiry, W. S. Repair defect in p21WAF1/CIP1 -/-human cancer cells. Cancer Res., 56: 2250-2255, 1996.
55. Waldman, T., Zhang, Y., Dillehay, L., Yu, J., Kinzler, K., Vogelstein, B., and Williams, J. Cell-cycle arrest versus cell death in cancer therapy. Nat. Med., 3: 1034-1036, 1997.